Harrow (HROW) Acquisitions (2014 - 2015)
Harrow (HROW) posted quarterly Acquisitions of $3.0 million for Q1 2015, up 7429.27% year-over-year from $39910.9 in Q1 2014, and up 605.04% quarter-over-quarter from -$595000.0 in Q2 2014.
Harrow (HROW) Acquisitions (2014 - 2015) Analysis & Trends
Harrow's Acquisitions history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2015.
- In Q1 2015, Acquisitions rose 7429.27% year-over-year to $3.0 million; the TTM figure through Dec 2015 stood at $3.0 million (up 572.48% YoY), while the FY2025 annual figure was $4.4 million, changed N/A from the prior year.
- Acquisitions for Q1 2015 stood at $3.0 million, up from -$595000.0 in the prior quarter.
- The five-year high for Acquisitions was $3.0 million in Q1 2015, with the low at -$595000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 3.01 Mn |
| Jun 30, 2014 | -595,000.00 |
| Mar 31, 2014 | -41,000.00 |